Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane

Impact of Diabetes on the Incidence of Contrast-Induced Nephropathy

The Reno-protective effect of SGLT-2 inhibitors in non-diabetic patients. A comparative review

Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in st

Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients

Efficacy of Colchicine Preloading in Mitigating Contrast-Induced Nephropathy in Diabetic Patients Undergoing Percutaneous Coronary Intervention

Potential Cardio-protective Role of Dapagliflozin in Post Myocardial Infarction Patients

THE EFFECT OF ADMINISTRATION OF ASCORBIC ACID IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH RENAL IMPAIRMENT UNDERGOING CORONARY INTERVENTION

Dapagliflozin's Impact on Cardio-Renal Outcomes in Critically Ill Type 2 Diabetes Mellitus Patients

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats